AU2008248168B2 - Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof - Google Patents

Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof Download PDF

Info

Publication number
AU2008248168B2
AU2008248168B2 AU2008248168A AU2008248168A AU2008248168B2 AU 2008248168 B2 AU2008248168 B2 AU 2008248168B2 AU 2008248168 A AU2008248168 A AU 2008248168A AU 2008248168 A AU2008248168 A AU 2008248168A AU 2008248168 B2 AU2008248168 B2 AU 2008248168B2
Authority
AU
Australia
Prior art keywords
methylpyrrolidine
methyl
tartrate
phenyl
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008248168A
Other languages
English (en)
Other versions
AU2008248168A1 (en
Inventor
Michael Christie
Joseph J. Petraitis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon LLC filed Critical Cephalon LLC
Publication of AU2008248168A1 publication Critical patent/AU2008248168A1/en
Application granted granted Critical
Publication of AU2008248168B2 publication Critical patent/AU2008248168B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2008248168A 2007-05-03 2008-05-02 Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof Ceased AU2008248168B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
US60/927,356 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (2)

Publication Number Publication Date
AU2008248168A1 AU2008248168A1 (en) 2008-11-13
AU2008248168B2 true AU2008248168B2 (en) 2013-03-21

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008248168A Ceased AU2008248168B2 (en) 2007-05-03 2008-05-02 Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof

Country Status (14)

Country Link
EP (1) EP2152669A1 (enExample)
JP (1) JP5698887B2 (enExample)
KR (1) KR20100017565A (enExample)
CN (1) CN101679237A (enExample)
AU (1) AU2008248168B2 (enExample)
BR (1) BRPI0810330A2 (enExample)
CA (1) CA2686033A1 (enExample)
EA (1) EA019031B1 (enExample)
IL (1) IL201627A (enExample)
MX (1) MX2009011787A (enExample)
NZ (1) NZ580948A (enExample)
UA (1) UA99913C2 (enExample)
WO (1) WO2008137087A1 (enExample)
ZA (1) ZA200907643B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52626B (sr) 2006-07-25 2013-06-28 Cephalon Inc. Derivati piridizinona
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
WO2009097306A1 (en) * 2008-01-30 2009-08-06 Cephalon, Inc. Substituted pyridazine derivatives which have histamine h3 antagonist activity
HK1244789B (en) * 2014-12-23 2019-12-06 Cephalon, Inc. Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives
AR116299A1 (es) * 2018-09-07 2021-04-21 Sanofi Sa Sales de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxilato de metilo y proceso de preparación de las mismas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
CN100543050C (zh) 2004-03-08 2009-09-23 独立行政法人科学技术振兴机构 高分子担载金属簇组合物
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
AU2005249196B2 (en) 2004-06-02 2011-06-09 F. Hoffmann-La Roche Ag Naphthaline derivatives useful as histamine-3-receptor ligands
CN101111480A (zh) 2004-12-01 2008-01-23 万有制药株式会社 取代的吡啶酮衍生物
WO2006066197A1 (en) 2004-12-17 2006-06-22 Janssen Pharmaceutica, N.V. Tetrahydroisoquinoline compounds for treatment of cns disorders
EP1848696A1 (en) 2005-01-21 2007-10-31 Schering Corporation Imidazole and benzimidazole derivates useful as histamine h3 antagonists
EP1866293A1 (en) 2005-03-31 2007-12-19 UCB Pharma, S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
US7943605B2 (en) 2005-10-27 2011-05-17 Ucb Pharma S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
DK1988777T3 (da) 2006-02-09 2012-01-16 Athersys Inc Pyrazoler til behandling af fedme og andre cns-lidelser
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
JP2009539762A (ja) 2006-03-13 2009-11-19 ファイザー・プロダクツ・インク H3受容体のテトラリン拮抗薬
WO2008005338A1 (en) 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
RS52626B (sr) * 2006-07-25 2013-06-28 Cephalon Inc. Derivati piridizinona

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAKURAI, R. et al., Crystal Growth and Design, 2006, vol 6, pages 1606-1610 *

Also Published As

Publication number Publication date
ZA200907643B (en) 2014-03-26
EA200971019A1 (ru) 2010-04-30
CN101679237A (zh) 2010-03-24
CA2686033A1 (en) 2008-11-13
NZ580948A (en) 2011-04-29
EP2152669A1 (en) 2010-02-17
UA99913C2 (ru) 2012-10-25
AU2008248168A1 (en) 2008-11-13
KR20100017565A (ko) 2010-02-16
JP2010526142A (ja) 2010-07-29
JP5698887B2 (ja) 2015-04-08
IL201627A0 (en) 2010-05-31
BRPI0810330A2 (pt) 2014-10-14
IL201627A (en) 2014-06-30
WO2008137087A1 (en) 2008-11-13
MX2009011787A (es) 2009-11-13
EA019031B1 (ru) 2013-12-30

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
JP6491393B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての1,3,4−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物
Lourdusamy et al. Stereoselective synthesis of α-diazo oxime ethers and their application in the synthesis of highly substituted pyrroles through a [3+ 2] cycloaddition
AU2008248168B2 (en) Processes for preparing (R)-2-methylpyrrolidine and (S)-2-methylpyrrolidine and tartrate salts thereof
CN111770918B (zh) Trpc6的抑制剂
AU2021308344B2 (en) Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
AU2008223145A1 (en) Tetrahydroisoquinoline compounds as modulators of the histamine H3 receptor
KR20230158007A (ko) 항바이러스 화합물
KR101685639B1 (ko) 신규한 인돌 유도체 화합물 및 이를 포함하는 약제학적 조성물
CA2791431A1 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
WO2010059393A1 (en) Serotonin receptor modulators
CN105801572B (zh) 一种利伐沙班的制备方法
JP6498672B2 (ja) 疼痛に対して多重モードの活性を有するピペリジン化合物
CN114728177A (zh) 作为Kv1.3钾Shaker通道阻滞剂的芳基杂二环化合物
ES2561834T3 (es) Naftiridonas y quinolonas 7-amino alquilidenil-heterocíclicas
JP2010526142A5 (enExample)
ZA200700950B (en) Pyrrole derivatives, their preparation and their therapeutic use
CN101142180A (zh) 作为组胺h3受体拮抗剂的吡咯烷衍生物
KR20230164136A (ko) Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로시클릭 화합물
AU2005252178A1 (en) Histamine H3 receptor agents, preparation and therapeutic uses
CN111471037A (zh) 烯丙基胺类化合物及其应用
JP7672386B2 (ja) オレキシン受容体調節薬としての(2h-1,2,3-トリアゾール-2-イル)フェニル化合物の改善された合成方法
WO2002089803A1 (fr) Composition d'ionophorese
Yoon‐Miller et al. Suzuki–Miyaura arylations of tetramic acid sulfonates: Evaluation of lactam protection, sulfonate esters, and sterics
OA19483A (en) Substituted indoline derivatives as dengue viral replication inhibitors.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired